Griffin, J. M., Baughan, E., Rosenblum, H., Clerkin, K. J., Fried, J. A., Raikhelkar, J., Uriel, N., Brannagan, T. H., Takeda, K., Grodin, J. L., Marboe, C., Maurer, M. S., & Farr, M. A. (2022). Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies. The Journal of Heart and Lung Transplantation, 41(2), 199–207. https://doi.org/10.1016/j.healun.2021.10.007
Subjects:
Antirheumatic Agents
(MeSH)
Heart Transplantation
(MeSH)
Population Surveillance
(MeSH)
Quality of Life
(MeSH)
Publication Type:
Article
Unique ID:
10.1016/j.healun.2021.10.007
PMID:
Publication Date:
Data Source:
Scopus